Showing posts with label metatastic prostate cancer. Show all posts
Showing posts with label metatastic prostate cancer. Show all posts

Thursday, July 2, 2009

Dietary fat from red meat and dairy linked to pancreatic cancer

29000 Men Comment
There seems to be a growing body of research clearly pointing to the relationship between dietary habits and cancers of all types. There is similar research concerning prostate cancer. These insights give each of us a means of affecting our current and future susceptibility to cancer. There currently are over 2 million prostate cancer survivors in the United States. A change in dietary intake could potentially have an important effect on longetivity.

Report Summary
High intake of dietary fats from red meat and dairy products was associated with an increased risk of pancreatic cancer, revealed by researchers. This study was undertaken because research relating fat intake to pancreatic cancer was inconclusive.

The new study is published online June 26 in the Journal of the National Cancer Institute.

To examine the association, Rachael Z. Stolzenberg-Solomon, Ph.D., of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute in Bethesda, Md., and colleagues analyzed a cohort of over 500,000 people from the National Institutes of Health – AARP Diet and Health Study.

Participants completed a food frequency questionnaire in 1995 and 1996 and were followed prospectively for an average of 6 years to track a variety of health outcomes, including pancreatic cancer.

Men and women who consumed high amounts of total fats had 53% and 23% higher relative rates of pancreatic cancer, respectively, compared with men and women who had the lowest fat consumption. Participants who consumed high amounts of saturated fats had 36% higher relative rates of pancreatic cancer compared with those who consumed low amounts.

"We observed positive associations between pancreatic cancer and intakes of total, saturated, and monounsaturated fat overall, particularly from red meat and dairy food sources. We did not observe any consistent association with polyunsaturated or fat from plant food sources," the authors write. "Altogether, these results suggest a role for animal fat in pancreatic carcinogenesis."

In an accompanying editorial, Brian M. Wolpin, M.D., MPH, of the Dana Farber Cancer Institute in Boston and Meir J. Stampfer, M.D., DrPH, of the Harvard School of Public Health, call the study well-performed and a good addition to the understanding of pancreatic cancer.

They do note, however, that there is insufficient epidemiological and laboratory evidence to confirm the importance of animal fats or even that meat is the important factor, as opposed to other dietary or lifestyle preferences associated with meat consumption.

"With further investigation, this work has the potential to provide interesting clues to the mechanisms underlying pancreatic tumorigenesis," the editorialists write.

Sunday, June 7, 2009

UroToday - Excellent Prostate Cancer Resource Center

29000Men Comment
This is an excellent resource for those of us who like to look at actual research being done in the medical community. This is very informative if you take the time to educate yourself. There is an excellent summary of new work being done in prognostic nomograms.

UroToday
UroToday's Prostate Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of prostate cancer. Also available are conference coverage for all timely prostate cancer science, streaming media presentations, audio podcasts and downloadable slides from UroToday's slide library.

http://www.urotoday.com/browse_categories/prostate_cancer/1014/

Sunday, May 31, 2009

Test, Track, Treat - or Die!

Wow. This is a really downer of a tagline. I hope it will cause you to read further.

I attended an exposition yesterday on successful aging, sponsored the the Daily Breeze, our local South Bay newspaper (Los Angeles area). I was talking with vendors about participating in our prostate cancer / breast cancer awareness event November 9th, 2009 at the velodrome at the Home Deport Center in Carson, CA.

Speaking with one of the vendors, I heard another story about a man, aged 54, just diagnosed with Stage 4 prostate cancer, already metastasized to bone. This makes me wonder what it will take for men to come to grips with the self-induced fear about digital rectal examinations (DRE). Most of us played sports in our youth and experienced sprained joints, broken limbs, painful sunburns, jelly fish stings and possible a bouncing baseball to the tender private parts. A DRE isn’t as painful as any of these - nor are the needle biopsies if that should become necessary. Prostate cancer is the number two cancer killer of men, approximately 29,000 men each year, and the incidence of prostate cancer is rising. Despite massive investments in research, there is no effective cure for cancer. Ideally we will learn at some point the causes for cancer and be able to take preventative measure. Until that time, the best we can do is detect cancer sufficiently early that we can treat it where possible. Prostate cancer is highly treatable if cause early, prior to metastasis.

Here’s my personal prescription:


  1. Test. Beginning at age 35, have an annual PSA test (until something better is developed).

  2. Track. Track the change - hopefully there is none - and discuss it with your doctor. Track the data on your refrigerator door. Download and print one of simple PSA trackers from our website.

  3. Treat. If you fall into the unfortunate group of about 200,000 men who are diagnosed each year, work with your doctor to determine your best course of treatment.

  4. Live. If you’ve done all this, move to a healthy diet and exercise, and you’ve probably done all you can.


Finally, take a moment and encourage your friends to follow the same path.

Sunday, March 15, 2009

Prostate Cancer Survivor Preaches Testing

Convincing men to test for prostate cancer is an ongoing challenge. A recent article in the South Florida Times provides a great example. A 46 year old man recently diagnosed with prostate cancer organized a free seminar attended by 80 men. Of the 80, only 33 took a blood test (41%) and only 27 (34%) agreed to a digital rectal exam. We guys are a macho bunch, but there is a very real danger here. The 10-year survival rate for treatment prior to metastasis is 97%; for post-metatastic treatment the 10-year survival rate is only 17%. If we survivors can gently remind our colleagues about the need for testing and tracking the annual change - if any, we can make some significant inroads into late diagnoses. The Prostate Cancer Awareness Project is sending a rider across the US by bicycle in 2010 to raise funds for awareness events. Visit http://www.TourdeUSA.org and join the team.